Skip to content

SCHEDULE 13DAccepted May 7, 5:11 PM ET

Liminatus Pharma, Inc. SCHEDULE 13D

Valetudo Therapeutics LLC

Accepted (ET)

5:11 PM

May 7, 2025

Filed

May 7, 2025

Documents

2

Size

23.2 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.